Human and Animal Bites

Clinically reviewed Aug 13, 2026 Updated Aug 30, 2026

Clinical Snapshot

Bite wounds are polymicrobial inoculation injuries, not ordinary cellulitis. Human bites contain oral streptococci, Eikenella corrodens, and anaerobes; cat and dog bites frequently involve Pasteurella multocida and can involve Capnocytophaga canimorsus.[1] Good wound management, tetanus/rabies assessment, and recognition of deep structural injury are as important as antibiotics. Amoxicillin/clavulanate is 1st-line oral therapy because it reliably covers the expected mixed flora — narrower agents (cephalexin, cloxacillin, clindamycin, or macrolide monotherapy) do not.

Recognize the Condition

A dog bite wound with surrounding tissue injury
Dog bite wound — crush injury and laceration; tissue devitalization can extend well beyond the visible surface wound. (Nicor, CC BY-SA 3.0, Wikimedia Commons)

Bite patterns by source

Human bite

An open bite wound, or a small laceration over a knuckle after a punch. A closed-fist injury can penetrate the joint capsule or extensor tendon even when the skin wound looks minor.

Cat bite

Deep, narrow puncture wounds, often on the hand, with potentially rapid cellulitis or tenosynovitis.

Dog bite

Crush injury, laceration, or abrasion; tissue devitalization may be greater than the surface wound suggests.

Risk Factors

  • Hand, face, foot, or genital location.
  • Deep puncture or crush injury.
  • Delayed presentation.
  • Proximity to joint, tendon sheath, bone, or prosthetic joint.
  • Diabetes, immunosuppression, advanced liver disease, or asplenia.
  • Significant edema or vascular compromise.

Red Flags & Refer

Urgent/surgical assessment for any of the following:

  • A closed-fist human bite.
  • Hand tendon/joint involvement.
  • Neurovascular deficit.
  • Exposed bone.
  • Septic arthritis/tenosynovitis concern.
  • Severe crush injury.
  • Rapidly spreading infection.
  • Systemic toxicity.
  • Necrosis.
  • An immunocompromised/asplenic patient with significant infection.

Assessment & Diagnosis

  • Identify species/person, time of injury, and provoked/unprovoked animal behaviour.
  • Assess depth, contamination, tendon function, joint movement, neurovascular status, and any foreign body/tooth fragment.
  • Assess tetanus immunization status and give indicated prophylaxis per the current Canadian Immunization Guide.[2]
  • Complete a rabies exposure assessment using current public-health guidance — antibiotics do not replace rabies post-exposure prophylaxis.[3]
  • Culture only clinically infected wounds; do not routinely culture fresh uninfected bites.

Treatment Targets

  • Prevent or treat polymicrobial infection.
  • Protect tendon, joint, bone, and neurovascular structures.
  • Prevent tetanus and rabies when exposure warrants prophylaxis.
  • Achieve wound healing without trapping infection.

Choose Initial Treatment

Direct treatment rule

When antibiotic prophylaxis or treatment is indicated for a human, cat, or dog bite, choose amoxicillin/clavulanate first line — 875/125 mg PO Q12H, generally 3-5 days for prophylaxis or 5-10 days for established mild infection.

Beta-lactam allergy

Alternative: cefuroxime + metronidazole.

Alternative for severe allergy: doxycycline + metronidazole.

Moderate infection needing parenteral therapy

1st line: ceftriaxone + metronidazole.

Severe, limb-threatening infection

1st line: piperacillin/tazobactam.

Do not use cephalexin, cloxacillin, clindamycin, or macrolide monotherapy for animal bites — they do not reliably cover Pasteurella and the mixed oral flora.

Non-Pharmacologic Treatment

  • Copious irrigation is mandatory.
  • Debride devitalized tissue and remove foreign material.
  • Do not routinely close high-risk puncture wounds or infected wounds primarily.
  • Elevate an injured hand/limb.
  • Update tetanus immunization as indicated.
  • Complete rabies risk assessment and public-health consultation when appropriate.

Pharmacologic Treatment Options

Drug / interventionRoleDose / useImportant adverse effectsTeaching points
Amoxicillin/clavulanate
Preferred
Human, dog, or cat bite prophylaxis when indicated, and mild infected bites875/125 mg PO Q12H; prophylaxis 3-5 days, mild infection 5-10 daysGI effects, hypersensitivityCovers Staphylococcus, Streptococcus, Pasteurella, Capnocytophaga, and mouth anaerobes — no other single oral agent does.
Cefuroxime + Metronidazole
Alternative
Selected penicillin allergy needing anaerobic coverageCombo: cefuroxime 500 mg PO BID + metronidazole 500 mg PO BID-TIDGI effects; peripheral neuropathy with prolonged metronidazole useUse when cephalosporin use is acceptable.
Doxycycline + Metronidazole
Alternative
Severe penicillin allergy (adult)Combo: doxycycline 100 mg PO BID + metronidazole 500 mg PO BID-TIDPhotosensitivity, esophagitis; metronidazole GI effectsAvoid doxycycline in pregnancy.
Ceftriaxone + Metronidazole
Preferred (parenteral)
Moderate bite infection needing parenteral therapyCombo: ceftriaxone 1-2 g IV once daily + metronidazole 500 mg PO/IV Q8-12HHypersensitivity, GI effectsHospital/urgent-care pathway.
Piperacillin/tazobactam
Special situation
Severe limb-threatening polymicrobial infection3.375 g IV Q6HHypersensitivity, GI effects, cytopeniasReserve for severe infection requiring broad empiric coverage.

Special Populations

Pregnancy

Amoxicillin/clavulanate is preferred when susceptible/appropriate. Avoid doxycycline-based alternatives when another effective regimen is available.

Asplenia or severe immunocompromise

Use a lower threshold for prophylaxis, systemic therapy, and urgent assessment — Capnocytophaga infection can become severe rapidly in these patients.

Children

Use weight-based amoxicillin/clavulanate dosing. Any suspected joint/tendon/hand deep injury warrants medical assessment.

Monitoring & Follow-Up

High-risk bite wounds require reassessment within 24-48 hours. Worsening pain, reduced joint range of motion, new swelling, fever, or lymphangitic spread requires urgent review. Treatment duration should be extended for deeper infections such as tenosynovitis, septic arthritis, or osteomyelitis under specialist direction.

Treatment Failure / Next Step

  1. Re-examine for retained foreign body, devitalized tissue, or closed-space infection.
  2. Culture infected drainage.
  3. Confirm the regimen covers Pasteurella/Capnocytophaga/Eikenella and anaerobes as appropriate.
  4. Assess tendon, joint, and bone involvement.
  5. Escalate to IV therapy and surgery/infectious-diseases consultation when deep infection or systemic illness is present.

Common Errors to Avoid

  • Using cephalexin alone for a cat or dog bite.
  • Missing a closed-fist human bite because the skin wound is small.
  • Forgetting tetanus and rabies assessment.
  • Closing a contaminated puncture wound without considering infection risk.
  • Treating a deep hand infection with oral antibiotics alone.

Clinical Decision Algorithm

Algorithm A — Human bite
Human bite or closed-fist injury over the MCP joint
Immediate irrigation, wound exploration, assess tendon/joint involvement, tetanus status
Superficial, low-risk, no infection
If prophylaxis criteria met: amoxicillin/clavulanate for a short prophylactic course
Closed-fist, hand/face, deep puncture, joint/tendon concern, infected, or delayed presentation
Urgent medical/surgical assessment; amoxicillin/clavulanate for mild infection or IV broad-spectrum therapy if moderate/severe
Algorithm B — Cat bite
Cat bite, usually a deep puncture wound
Copious irrigation; assess hand/joint/tendon involvement; tetanus + rabies risk assessment
Prophylaxis is generally indicated for deep cat bites/high-risk sites or hosts: amoxicillin/clavulanate
Any infection, rapidly spreading cellulitis, or deep-structure pain: urgent assessment; consider IV therapy if moderate/severe
Algorithm C — Dog bite
Dog bite / crush or laceration injury
Irrigate, debride devitalized tissue, assess neurovascular/tendon/bone injury, tetanus + rabies risk
Low-risk superficial wound
No routine antibiotic unless prophylaxis criteria are present; close wound-care follow-up
Moderate/severe wound, hand/face, bone/joint proximity, edema, immunocompromise/asplenia, or infection
Amoxicillin/clavulanate prophylaxis/treatment; severe infection → IV therapy and surgical assessment

Drug Tables

How to use this table: Doses are adult doses and require patient-specific confirmation (renal/hepatic function, weight, allergy history). Pediatric dosing is weight-based per the current product monograph unless stated. Drug pricing is intentionally omitted. Select any drug name to open its complete Pharmasist Drug Database page.

Oral therapy

DrugDosageAdverse effectsComments
Amoxicillin/clavulanate
Adults: 875/125 mg PO Q12H or 500/125 mg PO Q8H
Children: 40 mg/kg/day (amoxicillin component) divided Q8H PO (max 1750 mg/day)
GI effects, hypersensitivity1st line for prophylaxis and mild infected bites.
Cefuroxime + Metronidazole
Combo (adults): cefuroxime 500 mg PO BID + metronidazole 500 mg PO BID-TID
Combo (children): cefuroxime 20-30 mg/kg/day divided Q12H PO + metronidazole 15-30 mg/kg/day divided Q8-12H PO
GI effects; metronidazole peripheral neuropathy with prolonged useSelected penicillin allergy.
Doxycycline + Metronidazole
Combo (adults only): doxycycline 100 mg PO BID + metronidazole 500 mg PO BID-TID
Photosensitivity/esophagitis; metronidazole GI effectsSevere penicillin allergy (adult); avoid doxycycline in pregnancy.

Parenteral therapy

DrugDosageAdverse effectsComments
Ceftriaxone + Metronidazole
Combo (adults): ceftriaxone 1-2 g IV once daily + metronidazole 500 mg PO/IV Q8-12H
Combo (children): ceftriaxone 50-75 mg/kg IV once daily (max 1000 mg/day) + metronidazole 15-30 mg/kg/day divided Q8-12H
Hypersensitivity, GI effectsModerate infection needing parenteral therapy.
Piperacillin/tazobactam
Adults: 3.375 g IV Q6H
Children: 240-300 mg/kg/day (piperacillin component) divided Q6-8H IV (max 16 g/day)
Hypersensitivity, GI effects, cytopeniasSevere limb-threatening polymicrobial infection.
Meropenem
Adults: 500 mg IV Q6H (institutional severe-infection dosing may differ)
Children: 10 mg/kg Q8H IV (max 500 mg/dose)
GI effects, hypersensitivityReserve for resistant polymicrobial pathogens under specialist direction.

References

  1. Microbiology of animal bite wound infections — Clinical Microbiology Reviews (Abrahamian FM, Goldstein EJ). Clin Microbiol Rev 2011;24(2):231-246
  2. Tetanus toxoid: Canadian Immunization Guide — Public Health Agency of Canada. Canadian Immunization Guide
  3. Rabies vaccine: Canadian Immunization Guide — Public Health Agency of Canada. Canadian Immunization Guide
  4. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America — Clinical Infectious Diseases (Stevens DL, Bisno AL, Chambers HF, et al.). Clin Infect Dis 2014;59(2):e10-e52

Professional reference only. Apply clinical judgment and verify patient-specific decisions against current authoritative guidance and product information.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.